In a human tumour that produced VIP, most of the RNA that encodes the peptide was the intron-containing precursor type.
In plain wordsIn lab tests of a human tumour that made VIP, most of the RNA for the body's own VIP was an unprocessed precursor form.
- Outcome
- Not applicableVIP precursor RNA in a human VIP-producing tumour
- Study
humann: not reported in source
Human tumour producing VIP- Outcome group
- Endogenous peptide levels · Cancer
Source sentences
By RNA blot analysis using a variety of genomic and cDNA-related probes we show that in a human tumor producing vasoactive intestinal peptide, most of the RNA encoding the peptide is of the precursor type.
This result measures the body's own Vasoactive intestinal peptide (VIP, aviptadil). Nobody was given the peptide. It is not evidence about taking it.